Filing Flows › Organon (OGN) › Capital expenditures
Organon (OGN) capital expenditures by quarter
Organon's capital expenditures were $44.0M in Q3 2026 (third quarter 2026), +5% from Q2 2026. Over the last 7 quarters it ranged from $32.0M (Q1 2025) to $46.0M (Q3 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $44.0M | +5% | -4% |
| Q2 2026 | $42.0M | +14% | +8% |
| Q1 2026 | $37.0M | -18% | +16% |
| Q4 2025 | $45.0M | -2% | — |
| Q3 2025 | $46.0M | +18% | — |
| Q2 2025 | $39.0M | +22% | — |
| Q1 2025 | $32.0M | — | — |
Q3 2026 at a glance
Organon, Q3 2026: revenue $1.6B (-2% year over year), operating margin 16.2%, net earnings $164M, operating cash flow $370M. The chart follows the revenue to costs, profit and cash.
Questions
What is Organon's capital expenditures?
Organon's capital expenditures were $44.0M in Q3 2026 (third quarter 2026), +5% from Q2 2026.
How has Organon's capital expenditures changed?
Over the last 7 quarters it ranged from $32.0M (Q1 2025) to $46.0M (Q3 2025).